SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-054088
Filing Date
2024-04-29
Accepted
2024-04-29 16:31:10
Documents
8
Period of Report
2024-07-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242729-1_def14a.htm DEF 14A 1254578
2 GRAPHIC bc_netloss-4c.jpg GRAPHIC 53695
3 GRAPHIC bc_share-4c.jpg GRAPHIC 60891
4 GRAPHIC lg_leaptherapeu-4c.jpg GRAPHIC 27914
5 GRAPHIC px_24leaptherapypxy1pg01-bw.jpg GRAPHIC 340357
6 GRAPHIC px_24leaptherapypxy1pg02-bw.jpg GRAPHIC 280275
7 GRAPHIC sg_chrismirabelli-bwlr.jpg GRAPHIC 6670
8 GRAPHIC sg_douglaseonsi-bw.jpg GRAPHIC 7338
  Complete submission text file 0001104659-24-054088.txt   2262857
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37990 | Film No.: 24891502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)